PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice.

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

NCT04601753.

Keyphrases